Evidence map›Paper›PMID 32477057›Full record

ArticleFrontiers in neuroscience2020

Reduced Post-ischemic Brain Injury in

Koji Tanaka, Shoji Matsumoto, Takeshi Yamada, Ryo Yamasaki, Makoto Suzuki, Mizuho A Kido, Jun-Ichi Kira

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07588932 (Relying on Pharmacotherapy to Improve Motor Gains of Robot-Assisted Upper-Extremity Rehabilitation in Chronic Stroke Survivors), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07588932 early_phase1recruitingnot on this mapstarted 2026, after this paper: background citation

Relying on Pharmacotherapy to Improve Motor Gains of Robot-Assisted Upper-Extremity Rehabilitation in Chronic Stroke Survivors

TypeinterventionalSponsorSpaulding Rehabilitation HospitalRan2026 to 2028Enrolled50ConditionsStrokeArmsTelmisartan, Metformin, Cilostazol
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Channels and Transporters in Ischemic Brain Edema.Journal of inflammation research · 2025
    Review
  3. Article
  4. "No-reflow" phenomenon in acute ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Review
  5. Review
  6. Article
  7. Astrocytic TRPV4 Channels and Their Role in Brain Ischemia.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Review
  10. TRPV4: A trigger of pathological RhoA activation in neurological disease.BioEssays : news and reviews in molecular, cellular and developmental biology · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Koji TanakaDepartment of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shoji MatsumotoDepartment of Comprehensive Strokology, School of Medicine, Fujita Health University, Toyoake, Japan.
Takeshi YamadaDepartment of Neurology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Ryo YamasakiDepartment of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Makoto SuzukiDepartment of Pharmacology, Division of Molecular Pharmacology, Jichi Medical University, Shimotsuke, Japan.
Mizuho A KidoDepartment of Anatomy and Physiology, Faculty of Medicine, Saga University, Saga, Japan.
Jun-Ichi KiraDepartment of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kyushu University · JPFujita Health University · JPJichi Medical University · JPSaga University · JPSaiseikai Fukuoka General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeIn the acute phase of ischemia-reperfusion, hypoperfusion associated with ischemia and reperfusion in microvascular regions and disruption of the blood-brain barrier (BBB) contribute to post-ischemic brain injury. We aimed to clarify whether brain injury following transient middle cerebral artery occlusion (tMCAO) is ameliorated in

methodstMCAO was induced in wild-type (WT) and

resultsCompared with WT mice,

conclusionThe present results demonstrate that TRPV4 contributes to post-ischemic brain injury. The preserved microcirculation and BBB function shortly after reperfusion are the key neuroprotective roles of TRPV4 inhibition, which represents a promising target for the treatment of acute ischemic stroke.

Indexed as

blood–brain barrierbrain edemaischemic strokeknockout micetransient receptor potential vanilloid 4

Identifiers

PMID32477057
PMCPMC7235376
OpenAlexW3021573204

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.